An Analysis of Cytomegalovirus-Specific Cell-Mediated Immunity in a Phase 3, Randomized, Placebo-Controlled Trial of Letermovir Prophylaxis in Cytomegalovirus-Seropositive Recipients of an Allogeneic Hematopoietic Cell Transplant. (academic.oup.com)

Authors: Papanicolaou GA … Badshah C Journal: Clinical Infectious Diseases Published: 2026-02-25 DOI: https://doi.org/10.1093/cid/ciaf646